Health coaching and genomics-potential avenues to elicit behavior change in those at risk for chronic disease: Protocol for personalized medicine effectiveness study in air force primary care

Global Advances In Health and Medicine

Volumn 2, Issue 3, 2013, Pages 26-38

  Vorderstrasse, Allison A ^a   Ginsburg, Geoffrey S ^a,b   Kraus, William E ^b,c   Maldonado, Maj Carlos J ^d   Wolever, Ruth Q ^b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Duke Schools of Medicine and Nursing   (United States)

^d DAVID GRANT MEDICAL CENTER   (United States)

Author keywords

Behavior change; Chronic disease; Coronary heart disease; Diabetes; Genomics; Health coaching

Indexed keywords

GLUCOSE; LIPID;

ADULT; AF COMPOSITE FITNESS SCORE; AIR FORCE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CLINICAL PROTOCOL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE COURSE; FEMALE; GENETIC RISK; GENOMICS; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HEALTH CARE; HEALTH COACHING; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COUNSELING; PENSIONER; PERSONALIZED MEDICINE; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SELF REPORT; SMOKING CESSATION; SOCIAL PSYCHOLOGY; UNITED STATES; WAIST CIRCUMFERENCE;

EID: 84904506590     PISSN: 2164957X     EISSN: 21649561     Source Type: Journal    
DOI: 10.7453/gahmj.2013.035     Document Type: Article

References (89)

1. CDC. National diabetes fact sheet 2007. http://www.cdc.gov/diabetes/pubs/pdf/ ndfs_2007.pdf. Accessed April 22, 2013.
2. CDC. Heart Disease. http://www.cdc.gov/nchs/fastats/heart.htm. Accessed April 22, 2013.
3. Robbins A, Chao S, Fonseca V, Snedecor M, Knapik J. Predictors of low physical fitness in a cohort of a active-duty U.S. air force members. AM J Prev Med. 2001;20(2):90-6.
4. Bray R, Hourani L, Olmstead K. 2002 Department of Defense survey of health related behaviors among military personnel. Research Triangle Park, NC: RTI International; 2005. Contract No.: RTI/7841/106-FR. http://www.dtic.mil/cgibin/GetTRDoc?AD=ADA431566. Accessed April 22, 2013.
5. Kress A, Hartzel M, Peterson M. Burden of disease associated with overweight and obesity among U.S. military retirees and their dependents, aged 38-64, 2003. Prev Med. 2005;41:63-9.
6. Paris R, Bedno S, Krauss M, Keep L, Rubertone M. Weighing in on type 2 diabetes in the military: characteristics of U.S. military personnel at entry who develop type 2 diabetes. Diabetes Care. 2001;24(11):11894-8.
7. Standards of medical care in diabetes--2013. Diabetes Care. 2013;36 SUPPL 1:S11-66.
8. Grundy SM, Howard B, Smith S Jr, Eckel R, Redberg R, Bonow RO. Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation. 2002;105(18):2231-9.
9. Redberg RF, Benjamin EJ, Bittner V, et al. AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. Circulation. 2009;120(13):1296-336.
10. Muller-Riemenschneider F, Reinhold T, Nocon M, Willich SN. Long-term effectiveness of interventions promoting physical activity: a systematic review. Prev Med. 2008;47(4):354-68.
11. Dansinger ML, Tatsioni A, Wong JB, Chung M, Balk EM. Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med. 2007;147(1):41-50.
12. Edelman D, Oddone EZ, Liebowitz RS, et al. A multidimensional integrative medicine intervention to improve cardiovascular risk. J Gen Intern Med. 2006;21(7):728-34. Epub 2006/07/01.
13. Wolever RQ, Dreusicke M, Fikkan J, et al. Integrative health coaching for patients with type 2 diabetes: a randomized clinical trial. Diabetes Educ. 2010;36(4):629-39.
14. Voils CI, Coffman CJ, Edelman D, et al. Examining the impact of genetic testing for type 2 diabetes on health behaviors: study protocol for a randomized controlled trial. Trials. 2012;13:121.
15. Grant RW, O'Brien KE, Waxler JL, et al. Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial. Diabetes Care. 2013;36(1):13-9.
16. Cho A, Vorderstrasse A, Suchindran S, et al. Preliminary 3-month outcomes of study of genetic risk testing for Type 2 diabetes in primary care settings. Society of General Internal Medicine Annual Meeting; May 7, 2012; Orlando, Florida.
17. Cho AH, Killeya-Jones LA, O'Daniel JM, et al. Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design. BMC Health Serv Res. 2012;12:16.
18. Christensen KD, Roberts JS, Uhlmann WR, Green RC. Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk. Genet Med. 2011;13(5):409-14.
19. Chao S, Roberts JS, Marteau TM, Silliman R, Cupples LA, Green RC. Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study. Alzheimer Dis Assoc Disord. 2008;22(1):94-7.
20. Cameron LD, Sherman KA, Marteau TM, Brown PM. Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychol. 2009;28(3):307-16.
21. Grant RW, Hivert M, Pandiscio JC, Florez JC, Nathan DM, Meigs JB. The clinical application of genetic testing in type 2 diabetes: a patient and physician survey. Diabetologia. 2009;52(11):2299-305.
22. Sanderson SC, Wardle J, Jarvis MJ, Humphries SE. Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK. Prev Med. 2004;39(3):458-64.
23. Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006;355(3):241-50.
24. Martin SN, Crownover BK, Kovach FE. Clinical inquiries. What's the best way to motivate patients to exercise? J Fam Pract. 2010;59(1):43-4.
25. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
26. Bairey Merz CN, Alberts MJ, Balady GJ, et al. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease. J Am Coll Cardiol. 2009 Sep 29;54(14):1336-63.
27. Bowles S, Picano J, Epperly T, Myer S. The LIFE program: a wellness approach to weight loss. Mil Med. 2006;171(11):1089-94.
28. Nelson M, Robbins A, Thornton J. An intervention to reduce excess body weight in adults with or at risk for type 2 diabetes. Mil Med. 2006;171(5):409-14.
29. D'Agostino RB, Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286(2):180-7.
30. Stone NJ, Bilek S, Rosenbaum S. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. Am J Cardiol. 2005;96(4A):53E-9E.
31. Sheridan SL, Viera AJ, Krantz MJ, Ice CL, Steinman LE, Peters KE, et al. The effect of giving global coronary risk information to adults: a systematic review. Arch Intern Med. 2010;170(3):230-9.
32. Mochan E, Ebell M. Risk-assessment tools for detecting undiagnosed diabetes. American family physician. 2009;80(2):175-8.
33. Palomaki GE, Melillo S, Bradley LA. Association between 9p21 genomic markers and heart disease: a meta-analysis. JAMA. 2010;303(7):648-56.
34. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316(5830):1491-3.
35. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316(5830):1488-91.
36. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357(5):443-53.
37. Talmud PJ, Cooper JA, Palmen J, et al. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clin Chem. 2008;54(3):467-74.
38. Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med. 2009;150(2):65-72.
39. Brautbar A, Ballantyne CM, Lawson K, et al. Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study. Circ Cardiovasc Genet. 2009 Jun;2(3):279-85.
40. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010;363(24):2339-50.
41. Dreyfuss JM, Levner D, Galagan JE, Church GM, Ramoni MF. How accurate can genetic predictions be? BMC Genomics. 2012;13:340.
42. Prudente S, Dallapiccola B, Pellegrini F, Doria A, Trischitta V. Genetic prediction of common diseases. Still no help for the clinical diabetologist! Nutr Metab Cardiovasc Dis. 2012;22(11):929-36.
43. Vassy JL, Donelan K, Hivert MF, Green RC, Grant RW. Genetic susceptibility testing for chronic disease and intention for behavior change in healthy young adults. J Community Genet. 2013;4(2):263-71.
44. Haga SB, Barry WT, Mills R, et al. Public knowledge of and attitudes toward genetics and genetic testing. Genet Test Mol Biomarkers. 2013;17(4):327-35.
45. Markowitz SM, Park ER, Delahanty LM, O'Brien KE, Grant RW. Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes. Diabetes Care. 2011;34(3):568-73.
46. Weedon MN, McCarthy MI, Hitman G, Walker M, Groves CJ, Zeggini E, et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med. 2006;3(10):e374.
47. Appel LJ, Clark JM, Yeh HC, et al. Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med. 2011;365(21):1959-68.
48. Dreusicke MH, Fenster A, Skinner B, et al. Pharmacy claims data support the effectiveness of integrative health coaching for patients with type II diabetes. Poster presented at the 71st Scientific Sessions of the American Diabetes Association. San Diego, CA. June 2011.
49. Marteau TM, Weinman J. Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med. 2006;62(6):1360-8.
50. Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: Using common sense to understand treatment adherence and affect cognition interaction. Cognitive Ther Res. 1992;16(2):143-63.
51. Kaufman C. Positive psychology: the science at the heart of coaching. In: Stober DR, Grant AM, editors. Evidence-based coaching handbook. Hoboken NJ: John Wiley and Sons; 2006.
52. DeShazer S. Keys to solution in brief therapy. New York: Norton; 1985.
53. O'Hanlon B. Guide to possibility land. New York: Norton; 1999.
54. O'Hanlon B. Do one thing different. New York: Morrow; 1999.
55. Wolever RQ, Caldwell KL, Wakefield JP, et al. Integrative health coaching: an organizational case study. Explore (NY). 2011;7(1):30-6.
56. Deci E, Ryan R. Intrinsic motivation and self-determination in human behavior. New York: Plenum; 1985.
57. Sheldon KM, Elliot AJ. Goal striving, need satisfaction, and longitudinal wellbeing: the self-concordance model. J Pers Soc Psychol. 1999;76(3):482-97.
58. Cohn MA, Fredrickson BL. In search of durable positive psychology interventions: Predictors and consequences of long-term positive behavior change. The journal of positive psychology. 2010;5(5):355-66.
59. Stober DR, Grant AM, editors. Evidence based coaching handbook: putting best practices to work for your clients. Hoboken, NJ: Wiley; 2006:219-53.
60. Locke EA, Latham GP. Building a practically useful theory of goal setting and task motivation. A 35-year odyssey. Am Psychol. 2002;57(9):705-17.
61. Pearson ES. Goal setting as a health behavior change strategy in overweight and obese adults: a systematic literature review examining intervention components. Patient Educ Couns. 2012;87(1):32-42.
62. Sheldon K. The self-concordance model of healthy goal-striving: when personal goals correctly represent the person. In: Deci E, Ryan R, editors. Handbook of self-determination research. Rochester, NY: University of Rochester Press; 2002.
63. Sheldon K, Kasser T. Pursuing personal goals: skills enable progress but not all progress is beneficial. Pers Soc Psychol Bull. 1998;24:1319-31.
64. Stober D, Grant A, editors. Evidence-based coaching handbook. Hoboken, NJ: John Wiley and Sons; 2006.
65. Marteau T, Senior V, Humphries SE, et al. Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial. Am J Med Genet. 2004;128A(3):285-93.
66. Bates BR, Templeton A, Achter PJ, Harris TM, Condit CM. What does "a gene for heart disease" mean? A focus group study of public understandings of genetic risk factors. Am J Med Genet. 2003;119A(2):156-61.
67. Leighton JW, Valverde K, Bernhardt BA. The general public's understanding and perception of direct-to-consumer genetic test results. Public Health Genom. 2012;15(1):11-21.
68. McPherson E. Genetic diagnosis and testing in clinical practice. Clin Med Res. 2006;4(2):123-9.
69. Miller TQ, Smith TW, Turner CW, Guijarro ML, Hallet AJ. A meta-analytic review of research on hostility and physical health. Psychol Bull. 1996;119(2):322-48.
70. Williams SC. Epigenetics. Proc Natl Acad Sci USA. 2013;110(9):3209.
71. Vorderstrasse A, Cho A, Wolever R. Clinical utility of genetic risk assessment in common chronic diseases: T2D and CHD-feasibility and preliminary data. International Society of Nurses in Genetics Annual Conference; October 27, 2012; Philadelphia, PA.
72. Wolever RQ, Webber DM, Meunier JP, Greeson JM, Lausier ER, Gaudet TW. Modifiable disease risk, readiness to change, and psychosocial functioning improve with integrative medicine immersion model. Altern Ther Health Med. 2011;17(4):38-47.
73. Smith LL, Lake NH, Simmons LA, Perlman A, Wroth S, Wolever RQ. Integrative health coach training: a model for shifting the paradigm toward patient-centricity and meeting new national prevention goals. Global Adv Health Med. 2013;2(3):52-60. DOI: 10.7453/gahmj.2013034.
74. Caldwell KL, Grey J, Wolever RQ. The process of patient empowerment in integrative health coaching: How does it happen? Global Adv Health Med. 2013;2(3):34-43. DOI: 10.7453/gahmj.2013.026
75. Liebowitz R; Smith L, editors. The Duke encyclopedia of new medicine: conventional and alternative medicine for all ages. New York: Rodale; 2006.
76. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38-48.
77. Berger J. Adult development theory and executive coaching practice. In: Stober D, Grant A, editors. Evidence based coaching handbook. Hoboken, NJ: Wiley; 2006. p. 77-102.
78. Thompson FE, Midthune D, Subar AF, Kahle LL, Schatzkin A, Kipnis V. Performance of a short tool to assess dietary intakes of fruits and vegetables, percentage energy from fat and fibre. Public Health Nutr. 2004;7(8):1097-105.
79. Taylor-Piliae RE, Haskell WL, Iribarren C, et al. Clinical utility of the Stanford brief activity survey in men and women with early-onset coronary artery disease. J Cardiopulm Rehabil Prev. 2007;27(4):227-32.
80. Taylor-Piliae RE, Fair JM, Haskell WL, et al. Validation of the Stanford Brief Activity Survey: examining psychological factors and physical activity levels in older adults. J Phys Act Health. 2010;7(1):87-94.
81. Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631-7.
82. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4 Pt 1):1005-26.
83. Prochaska JO, Velicer WF, Redding C, et al. Stage-based expert systems to guide a population of primary care patients to quit smoking, eat healthier, prevent skin cancer, and receive regular mammograms. Prev Med. 2005;41(2):406-16.
84. Diggle PJ, Heagerty P, Liang K-Y, Zeger SL. Analysis of longitudinal data. 2nd ed: Oxford: Oxford University Press; 2002.
85. Efron B, Tibshirani R. An introduction to the bootstrap. London: Chapman and Hall/CRC; 1994.
86. MacKinnon DPL, C M, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2004;7(1):83-104.
87. MacKinnon DP, Lockwood CM, Williams J. Confidence limits for the indirect effect: distribution of the product and resampling methods. Multivariate Behav Res. 2004;39(1):99.
88. Shrout PE, Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods. 2002;7(4):422-45.
89. Rochon J. Application of GEE procedures for sample size calculations in repeated measures experiments. Stat Med. 1998;17(14):1643-58.